ALPHAMAB-B (09966.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov26

Kangning Junrui Pharmaceutical-B Resolves to Repurchase Up to HKD 30 Million Ordinary Shares

06:15

Nov17

Knightsbridge Biopharma B Repurchased 350,000 Shares for HKD 3.4198 million

12:48

Nov11

XY Securities Gives 'Outperform' Rating to Conjecta-B

06:22

Nov10

CStone Pharmaceuticals-B Plans Open Market Share Repurchase

00:18

Nov7

Kangning Jierui Pharmaceutical-B Decides to Repurchase Up to 30 Million HKD Ordinary Shares

14:29

Kangning Pharmaceutical-B repurchased 560,000 shares for HKD5.261 million

11:14

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 174.82 M, Net Income 11.81 M, EPS 0.0109

Mar25

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 248.16 M, Net Income 112.36 M, EPS 0.1139

Aug15

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 93.25 M, Net Income -24.12 M, EPS -0.0268

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change